NOT-MH-19-037: Notice to Extend the Expiration Date of PAR-18-227, "Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)"

Notice to Extend the Expiration Date of PAR-18-227, "Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)"

Notice Number: NOT-MH-19-037

Key Dates
Release Date: August 7, 2019

Related Announcements
PAR-18-227

Issued by
National Institute of Mental Health (NIMH)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to extend the expiration date for PAR-18-227, Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) for one cycle. Due to the extension, the following application due date will be added:

Current Expiration Date: September 8, 2019

New Expiration Date: January 8, 2020

All the other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Enrique Michelotti, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-5415
Email: [email protected]